An allosteric ligand-binding site in the extracellular cap of K2P channels

Qichao Luo,Liping Chen,Xi Cheng,Yuqin Ma,Xiaona Li,Bing Zhang,Li Li,Shilei Zhang,Fei Guo,Yang Li,Huaiyu Yang

DOI: https://doi.org/10.1038/s41467-017-00499-3

IF: 16.6

2017-01-01

Nature Communications

Abstract:Two-pore domain potassium (K2P) channels generate leak currents that are responsible for the maintenance of the resting membrane potential, and they are thus potential drug targets for treating diseases. Here, we identify N-(4-cholorphenyl)-N-(2-(3,4-dihydrosioquinolin-2(1H)-yl)-2-oxoethyl)methanesulfonamide (TKDC) as an inhibitor of the TREK subfamily, including TREK-1, TREK-2 and TRAAK channels. Using TKDC as a chemical probe, a study combining computations, mutagenesis and electrophysiology reveals a K2P allosteric ligand-binding site located in the extracellular cap of the channels. Molecular dynamics simulations suggest that ligand-induced allosteric conformational transitions lead to blockage of the ion conductive pathway. Using virtual screening approach, we identify other inhibitors targeting the extracellular allosteric ligand-binding site of these channels. Overall, our results suggest that the allosteric site at the extracellular cap of the K2P channels might be a promising drug target for these membrane proteins.